Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Ottawa, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The global baby cleaning products market size was reached at US$ 3.58 billion in 2021. The rising awareness regarding the baby health and hygiene needs...
-
EfTEN Real Estate Fund III AS aktsia puhasväärtus (NAV) oli seisuga 31.01.2022 19,2489 eurot, kasvades jaanuari jooksul 0,7%. EPRA aktsia puhasväärtus (EPRA NRV - raamatupidamislik puhasväärtus ilma...
-
The net asset value (NAV) of EfTEN Real Estate Fund III AS was 19,2489 euros as of 31.01.2022, increasing by 0.7% during January. The net asset value of the EPRA share (EPRA NRV - net book value...
-
New York, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Instalment Payment Solution Market Research Report by Product, by Type, by Application, by Region -...
-
DUBAI, United Arab Emirates, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The power device analyzer market is projected to advance at a modest rate with a CAGR of 5% during the forecast period 2022-2032, as...
-
FREMONT, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced it...
-
SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
-
Company strengthens management team to capitalize on acquisitions and opportunities presented in its sports channels Lenexa, KS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ:...
-
NOVI, Mich., Feb. 10, 2022 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for...
-
YONKERS, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...